During the forum of business thinkers, Dmytro Shymkiv, also known as the Chairman of the Board of Directors representing the Darnytsia Group, said that the COVID-19 pandemic has become a severe stimulus to developing pharmaceutical companies around the world. Therefore, only after a year of the spread of coronavirus infection they could enter the rankings of most innovative companies. Ukrainian News Agency reported this on March 19.
